Nanotechnology-based inhalation treatments for lung cancer: state of the art

References

• RamalingamSSOwonikokoTKKhuriFRLung cancer: new biological insights and recent therapeutic advancesCA Cancer J Clin20116129111221303969
   PubMed Web of Science ®Google Scholar
• JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
   PubMed Web of Science ®Google Scholar
• American Lung AssociationTrends in Lung Cancer Morbidity and Mortality. Epidemiology and Statistics Unit, Research and Scientific Affairs Available from: http://www.lung.org/lung-disease/lung-cancer/learning-more-about-lung-cancer/understanding-lung-cancer/Accessed February 28, 2013
   Google Scholar
• FerlayJSoerjomataramIErvikMGLOBOCAN 2012 v1.0. Cancer Incidence and Mortality Worldwide: IARC Cancer Base Number 11 [Internet]Lyon, FranceInternational Agency for Research on Cancer2013 Available from: http://globocan.iarc.frAccessed December 13, 2013
   Google Scholar
• Cochrane Database of systematic reviewsChemotherapy can improve survival rates for nonsmall cell lung cancer Available from: http://summaries.cochrane.org/CD002139/chemotherapy-can-improve-survival-rates-for-non-small-cell-lung-cancerAccessed February 28, 2013
   Google Scholar
• LongoDLApproach to the patient with cancerFauciASBraunwaldEIssel-bacherKJHarrison’s Principles of Internal Medicine18th edNew York, NYMcGraw Hill2011493499
   Google Scholar
• KomakiRCoxJDMoss Radiation Oncology: Rationale, Technique, ResultsSt Louis, MOMosby-Year Book1994
   Google Scholar
• National Canscer InstituteSEER Stat Fact Sheet: Lung and Bronchus 2002–2008 Available from: http://seer.cancer.gov/statfacts/html/lungb.htmlAccessed December 19, 2012
   Google Scholar
• RoaWHAzarmiSAl-HallakMHInhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse modelJ Control Release2011150495521059378
   PubMed Web of Science ®Google Scholar
• LuJLiongMZinkJITamanoiFMesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugsSmall2007381341134617566138
   PubMed Web of Science ®Google Scholar
• KumarASahooSKPadheeKReview on solubility enhancement techniques for hydrophobic drugsInt J Comprehensive Pharmacy20113317
   Google Scholar
• TsengCLWuSYWangWHTargeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancerBiomaterials2008293014302218436301
   PubMed Web of Science ®Google Scholar
• SungJCPulliamBLEdwardsDANanoparticles for drug delivery to the lungsTrends Biotechnol20072556357017997181
   PubMed Web of Science ®Google Scholar
• AzarmiSRoaWHLobenbergRTargeted delivery of nanoparticles for the treatment of lung diseasesAdv Drug Deliv Rev20086086387518308418
   PubMed Web of Science ®Google Scholar
• AkhterSAminSAhmadJNanotechnology to combat multidrug resistance in cancerResistance to Targeted ABC Transporters in CancerSwitzerlandSpringer International Publishing2015245272
   Google Scholar
• AkhterSAhmadIAhmadMZNanomedicines as cancer therapeutics: current statusCurr Cancer Drug Targets201313436237823517593
   PubMed Web of Science ®Google Scholar
• RameshRNanoparticle-mediated gene delivery to the lungMethods Mol Biol200843430133118679632
   PubMedGoogle Scholar
• YuanDLvYYaoYEfficacy and safety of Abraxane in treatment of progressive and recurrent non-small cell lung cancer patients: a retrospective clinical studyThorac Cancer201234341347
   Web of Science ®Google Scholar
• PilcerGAmighiKFormulation strategy and use of excipients in pulmonary drug deliveryInt J Pharm201039211920223286
   PubMed Web of Science ®Google Scholar
• ZhangLJXingBWuJXuBFangXLBiodistribution in mice and severity of damage in rat lungs following pulmonary delivery of 9-nitrocamptothecin liposomesPulm Pharmacol Ther20082123924617561423
   PubMed Web of Science ®Google Scholar
• MansourHMRheeYSWuXNanomedicine in pulmonary deliveryInt J Nanomedicine2009429931920054434
   PubMed Web of Science ®Google Scholar
• AlipourSMontaseriHTafaghodiMPreparation and characterization of biodegradable paclitaxel loaded alginate microparticles for pulmonary deliveryColloids Surf B Biointerfaces20108152152920732796
   PubMed Web of Science ®Google Scholar
• MaedaHThe enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targetingAdv Enzyme Regul20014118920711384745
   PubMedGoogle Scholar
• SchreierHGagneLBockTPhysicochemical properties and in vitro toxicity of cationic liposome cDNA complexesPharm Acta Helv19977242152239372644
   PubMedGoogle Scholar
• KataokaKMatsumotoTYokoyamaMDoxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-l-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significanceJ Control Release20006414315310640653
   PubMed Web of Science ®Google Scholar
• KwonGNaitoMYokoyamaMOkanoTSakuraiYKataokaKBlock copolymer micelles for drug delivery: loading and release of doxorubicinJ Control Release199748195201
   Web of Science ®Google Scholar
• GillKKNazzalSKaddoumiAPaclitaxel loaded PEG5000–DSPE micelles as pulmonary delivery platform: formulation characterization, tissue distribution, plasma pharmacokinetics, and toxicological evaluationEur J Pharm Biopharm20117927628421575719
   PubMed Web of Science ®Google Scholar
• KalantarianPNajafabadiARHaririanIPreparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary deliveryInt J Nanomedicine2010576377021042422
   PubMed Web of Science ®Google Scholar
• TomodaKOhkoshiaTHirotaaKPreparation and properties of inhalable nanocomposite particles for treatment of lung cancerColloids Surf B Biointerfaces20097117718219264458
   PubMed Web of Science ®Google Scholar
• GoduguCPatelARDoddapaneniRMarepallySJacksonTSinghMInhalation delivery of Telmisartan enhances intratumoral distribution of nanoparticles in lung cancer modelsJ Control Release2013172869523838154
   PubMed Web of Science ®Google Scholar
• ChoiSHByeonHJChoiJSInhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancerJ Control Release201519719920725445703
   PubMed Web of Science ®Google Scholar
• AzarmiSTaoXChenHFormulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particlesInt J Pharm200631915516116713150
   PubMed Web of Science ®Google Scholar
• XieYAillonKLCaiSPulmonary delivery of cisplatin–hyaluronan conjugates via endotracheal instillation for the treatment of lung cancerInt J Pharm201039215616320363303
   PubMed Web of Science ®Google Scholar
• SubediRKKangKWChoiHKPreparation and characterization of solid lipid nanoparticles loaded with doxorubicinEur J Pharm Sci20093750851319406231
   PubMed Web of Science ®Google Scholar
• VideiraMAlmeidaAJFabraAPreclinical evaluation of a pulmonary delivered paclitaxel loaded lipid nanocarrier antitumor effectNanomedicine201281208121522206945
   PubMed Web of Science ®Google Scholar
• VideiraMABotelhoMFSantosACGouveiaLFDeLimaJJAlmeidaAJLymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticlesJ Drug Target20021060761312683665
   PubMed Web of Science ®Google Scholar
• HuLDJiaYDingWPreparation and characterization of solid lipid nanoparticles loaded with epirubicin for pulmonary deliveryPharmazie20106558558720824958
   PubMed Web of Science ®Google Scholar
• JyotiKKaurKPandeyRSJainUKChandraRMadanJInhalable nanostructured lipid particles of 9-bromo-noscapine, a tubulin-binding cytotoxic agent: in vitro and in vivo studiesJ Colloid Interface Sci201544521923025622047
   PubMed Web of Science ®Google Scholar
• TaratulaOKuzmovAShahMGarbuzenkoOBMinkoTNanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNAJ Control Release2013171334935723648833
   PubMed Web of Science ®Google Scholar
• PatlollaRRChouguleMPatelARJacksonTTataPNSinghMFormulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriersJ Control Release201014423324120153385
   PubMed Web of Science ®Google Scholar
• KhanOFZaiaEWJhunjhunwalaSDendrimer-inspired nano-materials for the in vivo delivery of siRNA to lung vasculatureNano Lett20151553008301625789998
   PubMed Web of Science ®Google Scholar
• KaminskasLMMcLeodVMRyanGMPulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapyJ Control Release2014183182624637466
   PubMed Web of Science ®Google Scholar
• PankhurstQAConnollyJJonesSKApplications of magnetic nanoparticles in biomedicineJ Phys D Appl Phys200336R167
   Web of Science ®Google Scholar
• AkhterSAhmadZSinghMCancer targeted metallic nanoparticle: targeting overview, recent advancement and toxicity concernCurr Pharm Des2011171834185021568874
   PubMed Web of Science ®Google Scholar
• VermaNKStauntonKCSattiAMagnetic core-shell nanoparticles for drug delivery by nebulizationJ Nanobiotechnology201311123343139
   PubMed Web of Science ®Google Scholar
• HeyderJDeposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug deliveryProc Am Thorac Soc2004131532016113452
   PubMedGoogle Scholar
• PlankCSchererFRudolphCLocalized nucleic acid delivery: a discussion of selected methodsSchleefMDNA PharmaceuticalsWeinheim, GermanyWiley-VCH Verlag GmbH & Co KGaA200555116
   Google Scholar
• PattonJSFishburnCSWeersJGThe lungs as a portal of entry for systemic drug deliveryProc Am Thorac Soc20041433834416113455
   PubMedGoogle Scholar
• TaratulaOGarbuzenkoOBChenAMMinkoTInnovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNAJ Drug Target2011191090091421981718
   PubMed Web of Science ®Google Scholar
• OkamotoHShirakiKYasudaRDanjoKWatanabeYChitosan–interferon-β gene complex powder for inhalation treatment of lung metastasis in miceJ Control Release201115018719521185340
   PubMed Web of Science ®Google Scholar
• TsengCLWangTWDongGCDevelopment of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targetingBiomaterials2007283996400517570484
   PubMed Web of Science ®Google Scholar
• TsengCLSuWYYenKCYangKC,LinFHThe use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalationBiomaterials2009303476348519345990
   PubMed Web of Science ®Google Scholar
• DamesPGleichBFlemmerATargeted delivery of magnetic aerosol droplets to the lungNat Nanotechnol20072849549918654347
   PubMed Web of Science ®Google Scholar
• SadhukhaTWiedmannTSPanyamJInhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapyBiomaterials201334215163517123591395
   PubMed Web of Science ®Google Scholar
• ShimGChoiHWLeeSEnhanced intrapulmonary delivery of anticancer siRNA for lung cancer therapy using cationic ethylphosphocholine-based nanolipoplexesMol Ther201321481682423380818
   PubMed Web of Science ®Google Scholar
• BermudezEMangumJBWongBAPulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particlesToxicol Sci200477234735714600271
   PubMed Web of Science ®Google Scholar
• ElderAGeleinRFinkelsteinJNDriscollKEHarkemaJOberdorsterGEffects of subchronically inhaled carbon black in three species. I. Retention kinetics, lung inflammation, and histopathologyToxicol Sci200588261462916177241
   PubMed Web of Science ®Google Scholar
• WarheitDBWebbTRReedKLPulmonary toxicity screening studies in male rats with TiO2 particulates substantially encapsulated with pyrogenically deposited, amorphous silicaPart Fibre Toxicol20063316438714
   PubMed Web of Science ®Google Scholar
• WarheitDBWebbTRReedKLFrerichsSSayesCMPulmonary toxicity study in rats with three forms of ultrafine-TiO2 particles: differential responses related to surface propertiesToxicology200723019010417196727
   PubMed Web of Science ®Google Scholar
• WarheitDBWebbTRSayesCMColvinVLReedKLPulmonary instillation studies with nanoscale TiO2 rods and dots in rats: toxicity is not dependent upon particle size and surface areaToxicol Sci200691122723616495353
   PubMed Web of Science ®Google Scholar
• LamCWJamesJTMcCluskeyRHunterRLPulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillationToxicol Sci200477112613414514958
   PubMed Web of Science ®Google Scholar
• MercerRRScabilloniJWangLAlteration of deposition pattern and pulmonary response as a result of improved dispersion of aspirated single-walled carbon nanotubes in a mouse modelAm J Physiol Lung Cell Mol Physiol200829418797
   Web of Science ®Google Scholar
• WarheitDBLaurenceBRReedKLRoachDHReynoldsGAWebbTRComparative pulmonary toxicity assessment of single-wall carbon nanotubes in ratsToxicol Sci200477111712514514968
   PubMed Web of Science ®Google Scholar
• CurtisJGreenbergMKesterJPhillipsSKriegerGNanotechnology and nanotoxicology: a primer for cliniciansToxicol Sci2006254245260
   Google Scholar
• HagensWIOomenAGde JongWHCasseeFRSipsAJWhat do we (need to) know about the kinetic properties of nanoparticles in the body?Regul Toxicol Pharmacol200749321722917868963
   PubMed Web of Science ®Google Scholar
• MoghimiSMHunterACMurrayJCNanomedicine: current status and future prospectsFASEB J200519331133015746175
   PubMed Web of Science ®Google Scholar
• OberdorsterGOberdorsterEOberdorsterJNanotoxicology: an emerging discipline evolving from studies of ultrafine particlesEnviron Health Perspect2005113782383916002369
   PubMed Web of Science ®Google Scholar
• MedinaCSantos-MartinezMJRadomskiACorriganOIRadomskiMWNanoparticles: pharmacological and toxicological significanceBr J Pharmacol2007150555255817245366
   PubMed Web of Science ®Google Scholar
• OberdorsterGSharpZAtudoreiVTranslocation of inhaled ultrafine particles to the brainInhal Toxicol2004166–743744515204759
   PubMed Web of Science ®Google Scholar
• LanoneSBoczkowskiJBiomedical applications and potential health risks of nanomaterials: molecular mechanismsCurr Mol Med20066665166317022735
   PubMed Web of Science ®Google Scholar
• BadeaIWettigSVerrallRFoldvariMTopical non-invasive gene delivery using gemini nanoparticles in interferon-gamma-deficient miceEur J Pharm Biopharm200765341442217292593
   PubMed Web of Science ®Google Scholar
• FernandezLSuaLFCamargoRBasanteMGutierrezOMunozJEvaluation of the pulmonary inflammatory response in murine biomodels exposed to modified titanium oxide (tio2-Modified)Biomedical Research2015123
   Google Scholar
• GarnettMCKallinteriPNanomedicines and nanotoxicology: some physiological principlesOccup Med (Lond)200656530731116868128
   PubMed Web of Science ®Google Scholar
• LacerdaLBiancoAPratoMKostarelosKCarbon nanotubes as nanomedicines: from toxicology to pharmacologyAdv Drug Deliv Rev200658141460147017113677
   PubMed Web of Science ®Google Scholar
• WitzmannFAMonteiro-RiviereNAMulti-walled carbon nanotube exposure alters protein expression in human keratinocytesNanomedicine20062315816817292138
   PubMed Web of Science ®Google Scholar
• SchinsRPKnaapenAMGenotoxicity of poorly soluble particlesInhal Toxicol200719118919817886067
   PubMed Web of Science ®Google Scholar